Such polymers display a change of conformation from extended chains to collapsed, hydrophobicallystabilized globular structures in response to acidification below their pK a ranges. [2] This change leads to increased binding of polymers to eukaryotic cell membranes and subsequent membrane disruption. [3] [4] [5] The pH-mediated conformational change depends principally on the balance between the hydrophobic interaction associated with hydrophobic moieties and the electrostatic repulsion resulting from charged carboxyl groups. [6] The hydrophobicity of pendant hydrophobic groups is one of the factors that influence the conformational behaviour of pH-responsive polymers. [3, 6, 7] Thus, the vinyl polymers poly(α-methylacrylic acid), poly(α-ethylacrylic acid) and poly(α-propylacrylic acid) undergo conformational change at progressively higher pH values, corresponding to increasing endosomal membrane lysis activity. [8] [9] [10] [11] [12] Eccleston et al. [13] [14] [15] described a biodegradable, metabolite-derived polyamide, poly(L-lysine iso-phthalamide) with a hydrophobic backbone and pendant carboxyl groups.
Despite lacking hydrophobic side chains presented in fusogenic peptides and poly(α-Submitted to alkylacrylic acid)s, poly(L-lysine iso-phthalamide) displays a pH-dependent conformational change [16] [17] [18] and weak cell membrane lytic capacity over a low pH range (pH 4.6 -5.0). [19, 20] Recently pH-responsive polymers have been synthesized by grafting hydrophobic amino acids, L-valine, L-leucine and L-phenylalanine, onto the carboxylic acid moieties along the backbone of poly(L-lysine iso-phthalamide). The effects of hydrophobicity and structure of grafted side chains and degree of grafting on the pH-responsiveness of polymer conformation and aggregation, cell membrane-disruptive activity, in-vitro cytotoxicity and intracellular trafficking of the grafted polymers have been demonstrated and presented elsewhere. [21] [22] [23] Of these derivatives, the polymer with the optimal properties for endosomal membrane disruption is the phenylalanine derivatized polymer PP-75 at a stoichiometric degree of substitution of 75 mol% (M = 24.9 kDa, degree of grafting = 63.2%). n [21, 22] In sheep erythrocyte models of endosomes, PP-75 was 35-fold more membrane-disruptive on a molar basis than the highly lytic bee-sting peptide melittin at pH 6. , whilst progressively decreased cell viability to 28% with increasing concentration up to 2 mg mL -1
. [22] Based on previous successful intracellular delivery of the model drug calcein, [22] it was thought that PP-75 may be able to deliver biological molecules (proteins and nucleic acids) through endosomal release. This study examines the ability of the synthetic polymer PP-75 to deliver Apoptin protein into mammalian cells. Apoptin, derived from Chicken Anemia Virus (CAV), has a relative molecular mass of 13.6 kDa. Apoptin has been shown to induce apoptosis in more than 70 different tumour cell lines, while leaving normal cells (i.e. primary fibroblasts, keratinocytes, smooth muscle cells, T cells, endothelial cells) unharmed. Though the exact mechanism(s) are still under investigation, two key processes (i.e. tumour-specific Submitted to phosphorylation and tumour-specific nuclear localization) are thought to play major roles in its unique activity. [24] Furthermore, Apoptin-mediated apoptosis is induced in a p53 and Bcl-2 independent manner, [25] making it a highly attractive therapeutic strategy for aggressive cancers. Exploitation of that strategy is, however, currently hampered by the lack of a clinically acceptable means of transporting Apoptin into cells. Currently, all studies of Apoptin delivery have been based on gene delivery or microinjection. [24] This [26] In all studies, MBP-Apoptin was used at a final concentration of 33 μg mL -1 (0.6 μM).
First, the uptake of FITC labeled PP-75 (PP-75-FITC) into Saos-2 cells was studied.
The Saos-2 cell line (ATCC HTB85) is derived from an osteogenic sarcoma from an 11 year old Caucasian female that underwent chemotherapy. [27] The cell line is p53 negative and serves as a model for tumours with missing or mutated p53. Flow cytometry experiments were conducted to quantify the polymer uptake after one hour incubation with PP-75-FITC. ) resulted in a large polymer structure that ran near 150 -75 kDa, indicating concentration-dependent hydrophobic association of the polymer.
The broad staining in these lanes may be due to the formation of variable-sized hydrophobic aggregates. [21] In-vitro, MBP-Apoptin spontaneously forms soluble, non-covalent, globular complexes approximately 80 nm in diameter. [28] Attributed to the N-terminal portion of Apoptin and stabilized by hydrophobic interactions, these complexes are composed of 30 -40 MBP-Apoptin subunits [28] and have estimated molecular weight of approximately 2.5 ± 0.3
MDa. [29] This multimerization of MBP-Apoptin accounts for its minimal migration in the leftmost lane of Fig. 1A . Interestingly, the concentration of PP-75 in Fig. 1A was sufficient to dissociate the multimeric MBP-Apoptin complex and resulted in a sharp band near 48 kDa (long arrow). MBP-Apoptin runs at 55.8 kDa band under denaturing conditions, [29] so 48 kDa is within the error (~15%) of using Native PAGE for molecular weight estimation. Complex dissociation is likely due to intercalation and solubilization of multimeric MBP-Apoptin globules by PP-75, enabling the migration of individual MBP-Apoptin subunits through the gel. The three faint bands surrounding MBP-Apoptin can be ascribed to three expression products (short arrows) consistently co-purified with MBP-Apoptin. [29] Based on the broad staining pattern near the top of the gel, PP-75 was unable to completely dissociate the MBPApoptin complex.
In to Saos-2 cells (Fig. 2) . As shown in Fig. 2A, a ) were found insufficient to dissociate the multimeric MBP-apoptin complexes (Fig. 1B) .
The presence of 5 μg mL Fig   1A) and suggests an optimum protein:polymer ratio for efficient protein transduction.
These flow cytometry data were validated by the studying the intracellular distribution and co-localization of MA-AF647 and PP-75-FITC using confocal microscopy. Fig. 3 displays evidence that PP-75 both enhances uptake and facilitates cytoplasmic release of MA-AF647. The image in Fig. 3A shows cells treated with 100 μg mL -1 PP-75-FITC alone. The diffuse staining pattern in the FITC channel is indicative of efficient release into the cytoplasm. [22, 30] The overlay image verifies that the diffuse staining is present within the cell membrane. Samples treated with MA-AF647 alone displayed evidence of the constitutive, low-level uptake of naked protein observed in flow cytometry experiments. Cells contained faint spots in the MA-AF647 channel (data not shown). The punctuate staining pattern suggests that naked MA-AF647 remains trapped in vesicular compartments. [22, 30] Viable cells incubated with unconjugated Alexa Fluor 647 did not show any fluorescence (data not shown).
Nuclear localization is a key step that precedes apoptosis induced by Apoptin. [31] As shown in MBP-Apoptin's proclivity to form large aggregates, comprised of 30 -40 monomers, the red punctate staining may simply be MBP-Apoptin aggregation. [29] Also, there are reports that MBP-Apoptin forms higher-order complexes with DNA [28] and this aggregation may increase with time. Although the extent of nuclear localization has not been determined, evidence of its possibility represents an exciting step towards the delivery of functional MBP-Apoptin.
The work presented here lays the basis for a novel protein delivery system using the 
Experimental
Protein Preparation: Cloning, expression, and purification of the MBP-Apoptin fusion protein has been described previously [29] . Briefly, the Apoptin open reading frame (ORF) was cloned into a pMalTB plasmid, which codes for MBP. A coding sequence was inserted to link the C-terminal end of MBP and N-terminus of Apoptin with aspartate residues and a thrombin consensus site [29] . E. coli BL21 cells were transformed with the plasmid construct and the expressed MBP-Apoptin was purified by double passage over an amylose column and eluted with 10 mM maltose. The eluate was loaded to an analytical cation exchanged column, washed, eluted with a linear gradient of NaCl and protein-containing fractions were dialyzed against phosphate buffered saline (PBS) and concentrated to 40 mg mL 
